Approval · Notice of Compliance 267 · 2003
ZITHROMAX: Notice of Compliance 267
Issued August 5, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 267
- Date
- August 5, 2003
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New 500 mg tablet strength and new dosing regimen (three day treatment) for acute bacterial exacerbations of chronic obstructive pulmonary disease in adults
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZITHROMAX | Not yet assigned | — |
| ZITHROMAX | 02247748 | Cancelled Pre Market |
Medicinal ingredients
- AZITHROMYCIN 250 MG per TAB
- AZITHROMYCIN 500 MG per TAB